Amino-aigéad fo dhìon GLP-1 airson atharrachadh slabhraidh taobh
Mion-fhiosrachadh Toraidh
| CHAN EIL. | Toraidhean | Àireamh CAS | Iarrtas | Prìomh Chomharra Càileachd | ||||
| Purrachd | Isomer | SI * | As motha * | Taiseachd | ||||
| 1 | Fmoc-Lys(Mtt)-OH | 167393-62-6 | Atharrachadh slabhraidh taobh lysine | ≥99.0% | ≤0.1% | ≤0.2% | ≤0.3% | ≤1.0% |
| 2 | Fmoc-Lys(Alloc)-OH | 146982-27-6 | Atharrachadh slabhraidh taobh lysine | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 3 | Fmoc-Lys(ivDde)-OH | 150629-67-7 | Atharrachadh slabhraidh taobh lysine | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 4 | Fmoc-Lys(Mmt)-OH | 159857-60-0 | Atharrachadh slabhraidh taobh lysine | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 5 | Fmoc-Glu-OtBu | 84793-07-7 | LiraglutideSemaglutide | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 6 | Glu-OtBu | 45120-30-7 | LiraglutideSemaglutide | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 7 | searbhag ochd-decanedioic | 871-70-5 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 8 | Eistear mono-tert-butyl searbhag ochd-deacanedioic | 843666-40-0 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 9 | tBu-OOC-C16-CO-Glu-OtBu | 1188328-39-3 | SemaglutideBloigh A | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 10 | AEEA | 134978-97-5 | SemaglutideAlbuvirtide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 11 | AEEA-OH.HCl | 134979-01-4 | SemaglutideAlbuvirtide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 12 | Fmoc-AEEA-OH | 166108-71-0 | SemaglutideAlbuvirtide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 13 | Boc-AEEA-OH | 108466-89-3 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 14 | AEEA-AEEA | 1143516-05-5 | Semaglutide | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 15 | Fmoc-AEEA-AEEA-OH | 560088-89-3 | SemaglutideBloigh B | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 16 | Octa(OtBu) -Glu(ɑ-OtBu)-AEEA-AEEA-OH | 1118767-16-0 | SemaglutideBloigh C | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 17 | tBu-OOC-C16-CO-Glu (AEEA-AEEA-NHS) -OtBu | 1118767-15-9 | SemaglutideBloigh D | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 18 | Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH | 1662688-20-1 | Bloigh Semaglutide E | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 19 | Boc-His(Trt)-OH | 32926-43-5 | Is e histidine an deireadh | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤4.0% |
| 20 | Fmoc-Aib-OH | 94744-50-0 | Semaglutide | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 21 | Boc-His(Trt)-Aib-OH | 2061897-68-3 | Semaglutide | ≥99.0% | ≤0.1% | ≤0.2% | ≤0.3% | ≤2.0% |
| 22 | Fmoc-Glu(OtBu)-Gly-OH | 866044-63-5 | Analog GLP-1 | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 23 | Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH | 1169630-31-2？ | Bloigh Semaglutide F | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 24 | Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS | 1169630-40-3 | Bloigh Semaglutide G | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 25 | Fmoc-Arg(pbf)-Gly-OH | 660846-80-0 | Analog GLP-1 | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 26 | Fmoc-Ala-Ala-OH | 87512-31-0 | Analog GLP-1 | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 27 | Fmoc-Thr(tBu)-Phe-OH | 1260609-75-3 ? | Analog GLP-1 | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 28 | searbhag pailmiteach | 1957/10/3 | Bloigh Liraglutide 1 | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 29 | Palm-Glu-OtBu | NA | Bloigh Liraglutide 2 | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 30 | Palm-Glu(NES)-OtBu | NA | Bloigh Liraglutide 3 | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 31 | Fmoc-Lys(Palm-Glu-OtBu)-OH | 1491158-62-3 | Liraglutide | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 32 | searbhag heicsadecanedioic | 505-54-4 | Insulin degludec | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 33 | Eistear mono-tert-butyl searbhag heicsadecanedioic | 843666-27-3 | Insulin degludec | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 34 | tBu-OOC-C14-CO-Glu-OtBu | NA | Bloigh I de insulin degludec | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 35 | tBu-OOC-C14-CO-Glu(NES)-OtBu | NA | Bloigh II de insulin degludec | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
SI * = Neo-ghlainead Sònraichte
Max*= Neo-ghlainead neo-aithnichte as motha
Comharra eile:
- Aigéad aiseatach: ≤0.02% (A h-uile toradh)
- Acetate Ethyl: ≤0.5% (A h-uile toradh)
- Deoch làidir: ≤0.5% (A h-uile toradh)
Slàinteachas
Bithear a’ dèanamh slàinteachadh an t-siostaim cuairteachaidh, a’ gabhail a-steach an lùb agus an tanca stòraidh, le Pasteurization. Nuair a thèid slàinteachadh Pasteurization a dhèanamh, thèid an t-uisge glan anns an tanca a theasachadh suas gu 80°C agus tòisichidh e a’ cuairteachadh tron t-siostam cuairteachaidh. Mairidh an slàinteachadh 1 uair an dèidh dha 80°C a ruighinn. Bithear a’ dèanamh slàinteachadh gach ràithe. Chaidh leabhar-log slàinteachaidh an t-siostam uisge glan a sgrùdadh agus cha deach gluasad sam bith a chomharrachadh.
